Appleton Partners’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
NC
Appleton Partners's TEVA Position: Q3 2017 in Review
Appleton Partners sold out of Teva Pharmaceutical Industries (TEVA) in Q3 2017, closing a stake of 8,677 shares — an estimated $288K sold.
Appleton Partners first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $657K in Q1 2016. 538 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.
- Appleton Partners reported no remaining Teva Pharmaceutical Industries position as of Q3 2017 after selling out during the quarter.
- Appleton Partners sold 8,677 Teva Pharmaceutical Industries shares in Q3 2017, an estimated $288K.
- Appleton Partners first reported a position in Teva Pharmaceutical Industries in Q2 2013 and held it in 17 quarters.
- Appleton Partners's Teva Pharmaceutical Industries position peaked at $657K in Q1 2016.
- 538 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2017.
Based on Appleton Partners's 13F filing for Q3 2017, filed 12 Oct 2017.